Chief Accounting Officer
ImmunityBio, Inc. (IBRX)Equibles does not estimate personal net worth.
Get an email with a short summary when ImmunityBio, Inc. publishes a filing, an earnings call transcript or a press release.
Get IBRX alertsDavid Sachs is recorded as Chief Accounting Officer at ImmunityBio, Inc. (IBRX) since March 5, 2021 and CFO at ImmunityBio, Inc. (IBRX). The newest filing on record that lists David Sachs as CFO at ImmunityBio, Inc. (IBRX) is dated April 30, 2026. The proxy statement of ImmunityBio, Inc. reports total compensation of $4,244,543 for David Sachs in fiscal 2025, including a base salary of $591,711. Disclosed compensation is on record for 6 fiscal years. ImmunityBio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at ImmunityBio, Inc. includes Richard Adcock (CEO and Board Member), Patrick Soon-Shiong (Chairman and Board Member), Regan Lauer (Chief Accounting Officer) and 7 others.
2021-03-05–present
Start not stated–present
Last confirmed April 30, 2026
IBRX
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2021-03-05–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | ImmunityBio, Inc. (IBRX) | CFO | $591,711 | $4,244,543 |
| 2024 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | $574,515 | $3,381,607 |
| 2023 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | $537,525 | $1,058,082 |
| 2022 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | $521,039 | $1,661,562 |
| 2021 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | $423,451 | $4,936,677 |
| 2020 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | $442,999 | $643,596 |
No call appearances or filed executive changes recorded yet.
